Which has the lower trailing P/E, ALHC or ASTH?

ASTH has the lower trailing P/E: ALHC trades at 45.55 and ASTH at 45.03. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALHC or ASTH?

Over the past five years, ASTH grew revenue faster — ALHC at a 33.83% CAGR versus ASTH at 53.77%.

Is ALHC or ASTH more profitable?

ASTH runs the higher net margin — ALHC at 0.89% versus ASTH at 1.05%.

How have ALHC and ASTH total returns compared?

Over the past 5 years, ALHC delivered -12.15% and ASTH delivered -16.52% annualized total return. Past performance doesn't predict future results.

Alignment Healthcare, Inc. (ALHC) vs Astrana Health, Inc. (ASTH)

A side-by-side comparison of Alignment Healthcare, Inc. and Astrana Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALHC

Alignment Healthcare, Inc.

$1.76B

$8.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

ASTH

Astrana Health, Inc.

$1.83B

$36.81HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ALHC vs ASTH

growth of $100 · dividends reinvested · last 6y

ALHC -50.9% (-11.2%/yr)ASTH +41.5% (+6.0%/yr)ASTH compounded faster over this window

ALHC ASTH

ALHC vs ASTH: by the numbers

•ASTH is the larger company ($1.83B vs $1.76B market cap).
•ASTH trades at the lower trailing earnings multiple (45.03 vs 45.55 P/E), one valuation lens rather than an overall verdict.
•ASTH converts more revenue to profit (1.05% vs 0.89% net margin).
•ASTH grew revenue faster over the past five years (53.77% vs 33.83% CAGR).

Metrics side by side

Valuation

Metric	ALHC	ASTH
P/E ratio	45.55	45.03
Forward P/E	46.82	26.33
P/S ratio	0.39	0.47
P/B ratio	6.65	2.20
EV / EBITDA	16.18	13.43
FCF yield	N/A	8.68%

Profitability

Metric	ALHC	ASTH
Gross margin	12.55%	9.22%
Operating margin	1.20%	2.61%
Net margin	0.89%	1.05%
ROE	15.35%	4.88%
ROIC	9.23%	4.13%

Growth (annualized)

Metric	ALHC	ASTH
Revenue CAGR (5Y)	33.83%	53.77%
EPS CAGR (5Y)	N/A	-15.06%
FCF CAGR (5Y)	N/A	18.35%
Total return CAGR (5Y)	-12.15%	-16.52%

Frequently asked

Which has the lower trailing P/E, ALHC or ASTH?: ASTH has the lower trailing P/E: ALHC trades at 45.55 and ASTH at 45.03. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALHC or ASTH?: Over the past five years, ASTH grew revenue faster — ALHC at a 33.83% CAGR versus ASTH at 53.77%.
Is ALHC or ASTH more profitable?: ASTH runs the higher net margin — ALHC at 0.89% versus ASTH at 1.05%.
How have ALHC and ASTH total returns compared?: Over the past 5 years, ALHC delivered -12.15% and ASTH delivered -16.52% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALHC analysis Full ASTH analysis Interactive comparison tool

Dig into the metrics

Alignment Healthcare P/E ratio Astrana Health P/E ratio Alignment Healthcare ROE Astrana Health ROE Alignment Healthcare operating margin Astrana Health operating margin Alignment Healthcare revenue growth Astrana Health revenue growth Alignment Healthcare free cash flow Astrana Health free cash flow

Alignment Healthcare & Astrana Health appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.